NUVB Nuvation Bio Inc.
Healthcare$4.72-1.46%ClosedMarket Cap: $1.64B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$13.00
Target (Median)
$12.50
Target Range
$10.00 - $17.00
Upside from current price: 175.4%
Rating Distribution
2 Strong Buy7 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-05 | RBC Capital | maintain | Outperform | Outperform |
| 2026-05-05 | Wedbush | maintain | Outperform | Outperform |
| 2026-05-05 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-02 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-03 | UBS | maintain | Neutral | Neutral |
| 2026-03-03 | RBC Capital | maintain | Outperform | Outperform |
| 2026-02-10 | Wedbush | maintain | Outperform | Outperform |
| 2026-01-21 | RBC Capital | maintain | Outperform | Outperform |
| 2026-01-12 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-12-11 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.26 | $289.6M | 4 |
| Sun Dec 31 | $-0.20 | $386.9M | 6 |
| Mon Dec 31 | $-0.01 | $561.3M | 4 |
| Tue Dec 31 | $0.59 | $849.5M | 2 |